ClinicalTrials.govpublic full text
Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
squamous cell carcinoma of the head and neck (scchn), palbociclib, cetuximab, human papillomavirus, squamous cell carcinoma, head and neck cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879373
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.